Showing 581 - 600 results of 1,123 for search '"prostate"', query time: 0.10s Refine Results
  1. 581

    Prostate Cancer Patients' Perceptions Regarding the Relevance of a Digital Rectal Examination During Their Follow‐Up After Radiation Therapy by Clément Klein, Ninon Bosc, Sylvie Marty, Laura Calen, Candice Debard, Grégoire Robert, Thibaud Haaser

    Published 2025-01-01
    “…ABSTRACT Background Prostate cancer is an example of the undervaluation of clinical examinations in care of patients. …”
    Get full text
    Article
  2. 582
  3. 583
  4. 584

    Polymorphisms of Homologous Recombination RAD51, RAD51B, XRCC2, and XRCC3 Genes and the Risk of Prostate Cancer by Maria Nowacka-Zawisza, Ewelina Wiśnik, Andrzej Wasilewski, Milena Skowrońska, Ewa Forma, Magdalena Bryś, Waldemar Różański, Wanda M. Krajewska

    Published 2015-01-01
    “…A significant relationship was detected between the RAD51 gene rs1801320 polymorphism and increased prostate cancer risk. Our results indicate that the RAD51 gene rs1801320 polymorphism may contribute to prostate cancer susceptibility in Poland.…”
    Get full text
    Article
  5. 585
  6. 586
  7. 587
  8. 588
  9. 589

    Delphi study to identify consensus on patient selection for hydrogel rectal spacer use during radiation therapy for prostate cancer in the UK by Amit Bahl, Suneil Jain, Albert Edwards, Rhodri Saunders, Clive Peedell, Heather Ann Payne, James Andrew Thomas, Prantik Das, Amanda Hansson Hedblom, Emily Woodward

    Published 2022-07-01
    “…Objectives To identify consensus on patient prioritisation for rectal hydrogel spacer use during radiation therapy for the treatment of prostate cancer in the UK.Design Delphi study consisting of two rounds of online questionnaires, two virtual advisory board meetings and a final online questionnaire.Setting Radical radiation therapy for localised and locally advanced prostate cancer in the UK.Participants Six leading clinical oncologists and one urologist from across the UK.Interventions Rectal hydrogel spacer.Primary and secondary outcome measures None reported.Results The panel reached consensus on the importance of minimising toxicity for treatments with curative intent and that even low-grade toxicity-related adverse events can significantly impact quality of life. …”
    Get full text
    Article
  10. 590
  11. 591
  12. 592
  13. 593
  14. 594

    Primary Mature Cystic Teratoma Compressing the Prostate in a 28-Year-Old Male: A Case Report and Literature Review by Khalil Chalhoub, Rawad Abou Zahr, Elias Mansour, Mona Aoun, Michel Jabbour

    Published 2019-01-01
    “…We present a rare case of a 28-year-old male with 2-month history of lower urinary tract symptoms, who was found to have a primary mature cystic teratoma abutting the prostate.…”
    Get full text
    Article
  15. 595
  16. 596

    Gambaran Hasil Pemeriksaan Urine pada Pasien dengan Pembesaran Prostat Jinak di RSUP DR. M. Djamil Padang by Azia Putri Al Jamil, Dian Pertiwi, Dwitya Elvira

    Published 2018-03-01
    “…Pembesaran prostat jinak dapat menyebabkan terjadinya hambatan aliran urine, sehingga pasien akan merasakan keluhan pada saluran kemih bagian bawah atau Lower Urinary Tract Symptom (LUTS). …”
    Get full text
    Article
  17. 597

    Novel αβ Integrin-Targeted Peptide Probes for Prostate Cancer Imaging by Chiun-Wei Huang, Zibo Li, Hancheng Cai, Tony Shahinian, Peter S. Conti

    Published 2011-07-01
    “…Accumulating experimental evidence indicates that overexpression of α 2 β 1 integrin may correlate with progression in human prostate cancer. The objective of this study was to design a novel imaging probe based on the Asp-Gly-Glu-Ala (DGEA) peptide for near-infrared-fluorescent (NIRF) imaging of α 2 β 1 , integrin expression in prostate cancer. …”
    Get full text
    Article
  18. 598
  19. 599
  20. 600